Ligand Pharmaceuticals reported $176.54M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
Baxter International BAX:US USD 16.15B 125M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Glaxosmithkline GSK:US GBP 17.04B 2.29B
Harsco HSC:US USD 1.31B 12.06M
Insmed INSM:US USD 807.48M 366K
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Veracyte VCYT:US USD 500K 100K